title: [Role of positron emission tomography is the evaluation of digestive tract tumors].
abstract: Imaging and endoscopic techniques have taken an increasing part in the management of gastroenterological disorders. Among these techniques, FDG-PET imaging has emerged as a powerful tool in the management of several cancer diseases, including tumors of the digestive tract. In particular, the role of PET for diagnosing and staging recurrent colorectal cancers, and for differentiating mass forming pancreatitis from carcinoma is now well established. In this review, we will briefly discuss the place of PET imaging in the work-up of the tumors of the digestive tract.
authors.affiliation: Service de Médecine nucléaire, Université de Liège.
authors.forename: R
authors.initials: R
authors.lastname: Hustinx
authors.forename: P
authors.initials: P
authors.lastname: Paulus
authors.forename: F
authors.initials: F
authors.lastname: Daenen
authors.forename: B
authors.initials: B
authors.lastname: Detroz
authors.forename: P
authors.initials: P
authors.lastname: Honoré
authors.forename: N
authors.initials: N
authors.lastname: Jacquet
authors.forename: P
authors.initials: P
authors.lastname: Rigo
mesh_terms: D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging*; D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging*; D010195:Pancreatitis / Q000000981:diagnostic imaging; D014055:Tomography, Emission-Computed
chemical_list: D019788:Fluorodeoxyglucose F18